Xvivo Perfusion AB (publ) (XVIPF)
OTCMKTS · Delayed Price · Currency is USD
23.52
+0.30 (1.26%)
Feb 10, 2026, 9:30 AM EST
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of $638.12 million as of February 12, 2026. Its market cap has decreased by -48.06% in one year.
Market Cap
638.12M
Enterprise Value
619.30M
Revenue
88.11M
Ranking
n/a
PE Ratio
233.74
Stock Price
$23.52
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 56.07M to 638.12M, an increase of 1,038.06%. That is a compound annual growth rate of 19.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 638.12M | -0.22% |
| Dec 30, 2025 | 639.52M | -54.14% |
| Dec 30, 2024 | 1.39B | 35.52% |
| Dec 29, 2023 | 1.03B | 96.50% |
| Dec 30, 2022 | 523.72M | -42.34% |
| Dec 30, 2021 | 908.22M | -17.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OpGen | 340.99M |
| Tian'an Technology Group | 182.07M |
| Zomedica | 127.05M |
| Positron | 68.49M |
| RetinalGenix Technologies | 59.54M |
| CS Diagnostics | 55.94M |
| Guided Therapeutics | 33.69M |
| Vivos | 32.75M |